NO20074680L - Innretning for levering av TRPV1-agonister - Google Patents

Innretning for levering av TRPV1-agonister

Info

Publication number
NO20074680L
NO20074680L NO20074680A NO20074680A NO20074680L NO 20074680 L NO20074680 L NO 20074680L NO 20074680 A NO20074680 A NO 20074680A NO 20074680 A NO20074680 A NO 20074680A NO 20074680 L NO20074680 L NO 20074680L
Authority
NO
Norway
Prior art keywords
delivery
drug
drug delivery
trpv1 agonists
reservoir
Prior art date
Application number
NO20074680A
Other languages
English (en)
Inventor
Gene Jamieson
Keith Roger Bley
Naweed Muhammad
Original Assignee
Neurogesx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogesx Inc filed Critical Neurogesx Inc
Publication of NO20074680L publication Critical patent/NO20074680L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Beskrevet her blir legemiddelleveringsinnretninger som inkluderer et okklusivt støttelag og et legemiddeldepot inneholdende en TRPVI-agonist og et ikke-hydrofilt løsningsmiddel. Legemiddeldepoet kan ha ulike former, slik som en klistrende polymermatriks, flytende reservoar eller mikroreservoardråper. Fremgangsmåter for å fremstille og anvende legemiddelleveringsinnretningen blir også beskrevet.
NO20074680A 2005-02-14 2007-09-13 Innretning for levering av TRPV1-agonister NO20074680L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65292305P 2005-02-14 2005-02-14
PCT/US2006/005453 WO2006089012A2 (en) 2005-02-14 2006-02-14 Device for delivery of trpv1 agonists

Publications (1)

Publication Number Publication Date
NO20074680L true NO20074680L (no) 2007-11-13

Family

ID=36917039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074680A NO20074680L (no) 2005-02-14 2007-09-13 Innretning for levering av TRPV1-agonister

Country Status (11)

Country Link
US (1) US20060204561A1 (no)
EP (1) EP1858495A2 (no)
JP (1) JP2008530139A (no)
KR (1) KR20070121666A (no)
CN (1) CN101189000A (no)
AU (1) AU2006214289A1 (no)
BR (1) BRPI0607461A2 (no)
CA (1) CA2597651A1 (no)
NO (1) NO20074680L (no)
WO (1) WO2006089012A2 (no)
ZA (1) ZA200707492B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943166B2 (en) 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
EP1865933B1 (en) * 2005-03-30 2015-11-04 Vanderbilt Royalty Sub L.P. Low-concentration capsaicin patch and methods for treating neuropathic pain
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US20100292660A1 (en) * 2007-07-10 2010-11-18 Agis Kydonieus Dermal delivery device with ultrasonic weld
EA020208B1 (ru) * 2007-07-10 2014-09-30 Эджайл Терапьютикс, Инк. Устройство доставки в кожу с изолирующим слоем in situ
WO2009142993A1 (en) * 2008-05-21 2009-11-26 The Regents Of The University Of California Topical application of analgesic for pain relief
US9211274B2 (en) 2012-02-01 2015-12-15 Warsaw Orthopedic, Inc. TRPV1 compounds in a biodegradable polymer carrier
CA2932156A1 (en) * 2013-12-24 2015-07-02 The Procter & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
US11607026B2 (en) 2014-05-30 2023-03-21 Johnson & Johnson Consumer Inc. Device for delivery of skin care composition
EP3212162A2 (en) * 2014-10-31 2017-09-06 Avent, Inc. Method and articles for inhibiting bladder contractions
US10549129B2 (en) 2016-06-24 2020-02-04 The Procter & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
JP6635881B2 (ja) * 2016-06-27 2020-01-29 ユニ・チャーム株式会社 温感シート
CN115006374A (zh) * 2022-07-13 2022-09-06 广州文翰生物科技有限公司 香兰基丁醚在制备治疗头屑和体癣产品中的应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313958A (en) * 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
US4544668A (en) * 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4564633A (en) * 1983-07-14 1986-01-14 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4544669A (en) * 1983-07-14 1985-10-01 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4532139A (en) * 1983-07-14 1985-07-30 The Procter & Gamble Company Compounds and compositions useful for producing analgesia
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4927687A (en) * 1984-10-01 1990-05-22 Biotek, Inc. Sustained release transdermal drug delivery composition
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4892890A (en) * 1984-11-01 1990-01-09 G. D. Searle And Company External analgesic compositions
USRE37934E1 (en) * 1986-08-28 2002-12-10 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
JP2594485B2 (ja) * 1990-08-29 1997-03-26 アメリカ合衆国 カプサイシンまたはその誘導体もしくは類似体を含有する鳥用食物
US5221692A (en) * 1991-08-22 1993-06-22 National Science Council Ether linked and relatively nonpungent analogues of N-nonanoyl vanillylamide
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5505958A (en) * 1994-10-31 1996-04-09 Algos Pharmaceutical Corporation Transdermal drug delivery device and method for its manufacture
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5716643A (en) * 1995-06-07 1998-02-10 Hemosphere Inc. Large scale production of medicine coated crosslinked protein microspheres
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5869533A (en) * 1996-04-23 1999-02-09 Holt; Stephen D. Non-irritating capsaicin formulations and applicators therefor
JPH10120593A (ja) * 1996-10-16 1998-05-12 Sekisui Chem Co Ltd 抗真菌外用剤
EP1201241B8 (en) * 1997-03-13 2010-10-27 James N. Campbell Compositions containing capsaicin or capsaicin analogues and an anesthetic
EP0984781A1 (en) * 1997-05-27 2000-03-15 Algos Pharmaceutical Corporation Analgesic drug composition containing a capsaicinoid and potentiator therefor
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
AU741528B2 (en) * 1997-06-05 2001-12-06 Hemosphere, Inc. Fibrinogen-coated microspheres
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
PT1094781E (pt) * 1998-07-07 2008-10-08 Transdermal Technologies Inc Composições para administração transdérmica rápida e não irritante de agentes farmacologicamente activos e métodos para formulação de tais composições e sua administração
JP3211027B2 (ja) * 1998-11-13 2001-09-25 丸石製薬株式会社 カプサイシン含有外用剤
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
EP1299494B1 (en) * 2000-07-07 2010-08-25 A.V. Topchiev Institute of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US20030104085A1 (en) * 2001-12-05 2003-06-05 Yeomans David C. Methods and compositions for treating back pain
US20040126415A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor
US7943166B2 (en) * 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
DK1613297T3 (da) * 2003-04-14 2007-09-24 Lohmann Therapie Syst Lts Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin
JP5619337B2 (ja) * 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
US7244446B2 (en) * 2003-10-16 2007-07-17 Winston Laboratories, Inc. Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide
EP1865933B1 (en) * 2005-03-30 2015-11-04 Vanderbilt Royalty Sub L.P. Low-concentration capsaicin patch and methods for treating neuropathic pain

Also Published As

Publication number Publication date
BRPI0607461A2 (pt) 2009-09-08
CA2597651A1 (en) 2006-08-24
CN101189000A (zh) 2008-05-28
JP2008530139A (ja) 2008-08-07
KR20070121666A (ko) 2007-12-27
WO2006089012A3 (en) 2007-05-18
AU2006214289A1 (en) 2006-08-24
WO2006089012A2 (en) 2006-08-24
US20060204561A1 (en) 2006-09-14
ZA200707492B (en) 2009-02-25
EP1858495A2 (en) 2007-11-28

Similar Documents

Publication Publication Date Title
NO20074680L (no) Innretning for levering av TRPV1-agonister
UY27806A1 (es) Sistema que comprende una boquilla y una sistema de soporte
BRPI0803733A2 (pt) sistema de infusão e monitoramento médico habilitado para celular
SG11202001188TA (en) Pressure-sensitive adhesive composition for organic el display device, pressure-sensitive adhesive layer for organic el display device, pressure-sensitive adhesive layer attached polarizing film for organic el display devices, and organic el display device
AR046074A1 (es) Composiciones de recubrimiento que contienen solvente
BRPI0612612A2 (pt) compàsitos de celulose reconstituÍdos por lÍquido iânico como matrizes de suporte sàlido
BRPI0717615A8 (pt) Métodos, dispositivo de comunicação, elemento de rede e sistema
BR112013031078A2 (pt) emissor-receptor móvel, emissor-receptor de estação base, servidor de dados e aparelhos relacionados, métodos e programas de computadores
ES2570607T3 (es) Película revestida con un fluoropolímero, procedimiento para formar la misma, y composición líquida de fluoropolímero
BRPI0517534A8 (pt) aplicador para dispensar um fluido, e método para aplicar solução de preparação cirúrgica
BRPI0504402A (pt) pistola de adesivo, suporte para um componente adesivo, unidade de mistura, peça de conexão e método de uso da mesma
CL2009001248A1 (es) Compuestos derivados de indazolilo sustituido con fenilo, que actúan como moduladores de glucocorticoides; composición y combinación farmacéutica que comprenden a uno de los compuestos; y uso de los compuestos en la preparación de medicamentos para el tratamiento de enfermedades inflamatorias y respiratorias.
ATE428971T1 (de) Netzwerkterminal, lieferserver und client/server system zum liefern von betriebssystemdaten und anwendungsdaten
DK1372766T3 (da) Sprøjte til viskoelastiske opløsninger
WO2009061681A3 (en) Antagonists of pgd2 receptors
CL2007002790A1 (es) Compuestos derivados de 1h-indol y 1h-bencimidazol; composicion farmaceutica; y uso para el tratamiento de hipogonadismo, osteoporosis y cancer de prostata entre otros.
CL2008003024A1 (es) Compuestos derivados de alquilsulfonilbenzotiazol, moduladores del receptor de grelina; formulacion farmaceutica; y uso para el tratamiento de obesidad o sobrepeso, diabetes, sindrome metabolico, entre otras.
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
DK1729819T3 (da) Indgivelsesanordning til lægemidler, som er röntgenstråle-synlige
PA8628801A1 (es) Compuesto promotor de adherencia
NO20074556L (no) Dispenser for utlevering av medikament
BR112017014984A2 (pt) técnicas para gerenciar um cliente da rede remoto a partir de um aplicativo em um dispositivo móvel
BRPI0806828A2 (pt) método e dispositivo para evaporação de ingredientes ativos de uma solução líquida
EP3575380A4 (en) LIQUID CRYSTAL ALIGNMENT AGENT POLYMER, LIQUID CRYSTAL ALIGNMENT COMPOSITION COMPRISING THE SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME
NL1034956A1 (nl) Lichtdiffusieplaat, oppervlakemissie lichtbroninrichting en vloeibaar kristal weergave inrichting.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application